Christos E. Zois

Old Road Campus Research Building, Roosevelt Drive
Oxford, ENG OX37DQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Corrigendum to "Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients" [Translational Oncology, volume 49 (2024), 102106].

Corrigendum to "Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients" [Translational Oncology, volume 49 (2024), 102106].

Journal: Translational oncology
Published: April 12, 2025

Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effects.

Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effects.

Journal: Scientific reports
Published: February 03, 2025

Correction to: Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Correction to: Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Journal: Cancer & metabolism
Published: January 28, 2025

Autophagy Blockage Up-Regulates HLA-Class-I Molecule Expression in Lung Cancer and Enhances Anti-PD-L1 Immunotherapy Efficacy.

Autophagy Blockage Up-Regulates HLA-Class-I Molecule Expression in Lung Cancer and Enhances Anti-PD-L1 Immunotherapy Efficacy.

Journal: Cancers
Published: August 30, 2024

Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients.

Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients.

Journal: Translational oncology
Published: April 23, 2024

Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Journal: Cancer & metabolism
Published: September 08, 2023

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 27, 2023

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 23, 2022

Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.

Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.

Journal: Cell death & disease
Published: October 24, 2021

Clinical validation of optimised RT-LAMP for the diagnosis of SARS-CoV-2 infection.

Clinical validation of optimised RT-LAMP for the diagnosis of SARS-CoV-2 infection.

Journal: Scientific reports
Published: July 09, 2021

Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine.

Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine.

Journal: Medical oncology (Northwood, London, England)
Published: May 15, 2021

Unveiling Cancer Metabolism through Spontaneous and Coherent Raman Spectroscopy and Stable Isotope Probing.

Unveiling Cancer Metabolism through Spontaneous and Coherent Raman Spectroscopy and Stable Isotope Probing.

Journal: Cancers
Published: March 09, 2021
Showing 1-12 of 39

Last Updated: 09/26/2026